These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 23746792

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Proteasome activity is altered in skeletal muscle tissue of tumour-bearing rats a leucine-rich diet.
    Ventrucci G, Mello MA, Gomes-Marcondes MC.
    Endocr Relat Cancer; 2004 Dec; 11(4):887-95. PubMed ID: 15613461
    [Abstract] [Full Text] [Related]

  • 3. Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes.
    Yano CL, Ventrucci G, Field WN, Tisdale MJ, Gomes-Marcondes MC.
    BMC Cancer; 2008 Jan 28; 8():24. PubMed ID: 18226207
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
    Mirza KA, Pereira SL, Voss AC, Tisdale MJ.
    Nutrition; 2014 Jan 28; 30(7-8):807-13. PubMed ID: 24984997
    [Abstract] [Full Text] [Related]

  • 5. Physical exercise and a leucine-rich diet modulate the muscle protein metabolism in Walker tumor-bearing rats.
    Salomão EM, Toneto AT, Silva GO, Gomes-Marcondes MC.
    Nutr Cancer; 2010 Jan 28; 62(8):1095-104. PubMed ID: 21058197
    [Abstract] [Full Text] [Related]

  • 6. L-leucine dietary supplementation modulates muscle protein degradation and increases pro-inflammatory cytokines in tumour-bearing rats.
    Cruz B, Oliveira A, Gomes-Marcondes MCC.
    Cytokine; 2017 Aug 28; 96():253-260. PubMed ID: 28494385
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of attenuation of protein loss in murine C2C12 myotubes by D-myo-inositol 1,2,6-triphosphate.
    Russell ST, Siren PM, Siren MJ, Tisdale MJ.
    Exp Cell Res; 2010 Jan 15; 316(2):286-95. PubMed ID: 19716818
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A leucine-rich diet modulates the mTOR cell signalling pathway in the gastrocnemius muscle under different Walker-256 tumour growth conditions.
    Cruz B, Oliveira A, Ventrucci G, Gomes-Marcondes MCC.
    BMC Cancer; 2019 Apr 11; 19(1):349. PubMed ID: 30975087
    [Abstract] [Full Text] [Related]

  • 10. Amino acids and insulin act additively to regulate components of the ubiquitin-proteasome pathway in C2C12 myotubes.
    Sadiq F, Hazlerigg DG, Lomax MA.
    BMC Mol Biol; 2007 Mar 19; 8():23. PubMed ID: 17371596
    [Abstract] [Full Text] [Related]

  • 11. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.
    Wyke SM, Russell ST, Tisdale MJ.
    Br J Cancer; 2004 Nov 01; 91(9):1742-50. PubMed ID: 15477867
    [Abstract] [Full Text] [Related]

  • 12. Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle.
    Mirza KA, Tisdale MJ.
    Br J Cancer; 2014 Aug 26; 111(5):903-8. PubMed ID: 25101564
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.
    Whitehouse AS, Tisdale MJ.
    Br J Cancer; 2003 Sep 15; 89(6):1116-22. PubMed ID: 12966435
    [Abstract] [Full Text] [Related]

  • 14. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF).
    Lorite MJ, Smith HJ, Arnold JA, Morris A, Thompson MG, Tisdale MJ.
    Br J Cancer; 2001 Jul 20; 85(2):297-302. PubMed ID: 11461093
    [Abstract] [Full Text] [Related]

  • 15. The 'cancer cachectic factor'.
    Tisdale MJ.
    Support Care Cancer; 2003 Feb 20; 11(2):73-8. PubMed ID: 12560934
    [Abstract] [Full Text] [Related]

  • 16. NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.
    Wyke SM, Tisdale MJ.
    Br J Cancer; 2005 Feb 28; 92(4):711-21. PubMed ID: 15714207
    [Abstract] [Full Text] [Related]

  • 17. Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor.
    Gomes-Marcondes MC, Smith HJ, Cooper JC, Tisdale MJ.
    Br J Cancer; 2002 May 20; 86(10):1628-33. PubMed ID: 12085214
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.